LymeTimes Fall 2020

Dr. Neil Spector: A Legacy Remembered

JOIN & RECEIVE ACCESS TOLYMETIMES

Stand with us. Make our voice stronger. Join us in advocating for people with Lyme disease. All members receive online access to the Lyme Times and exclusive access to the member community.

News

Patients Should Have a Say in How Their Doctor Treats Them

Patients Should Have a Say in How Their Doctor Treats Them

Dr. Elizabeth Maloney reviews the uncertain science on treatment options for high-risk tick bites and Lyme rashes.

Lyme Disease Symptoms Could be Mistaken for COVID-19, with Serious Consequences

Lyme Disease Symptoms Could be Mistaken for COVID-19, with Serious Consequences

Keep an eye out for summer flu-like illnesses after spending time outdoors.

Health & Science

Government Response to COVID-19 Shows What Could Have Been Done for Lyme… But Wasn’t

Government Response to COVID-19 Shows What Could Have Been Done for Lyme… But Wasn’t

Just like cancer and Lyme treatment, treatment for COVID-19 isn’t a one-size-fits-all approach.

Treating Psychiatric Lyme Symptoms with Disulfiram

Treating Psychiatric Lyme Symptoms with Disulfiram

Leading expert on how Lyme disease affects the brain finds that disulfiram can help.

Lyme Infection, Mold Toxicity, and COVID-19 Can Affect the Brain, Digestive Tract and Immune System

Lyme Infection, Mold Toxicity, and COVID-19 Can Affect the Brain, Digestive Tract and Immune System

July 2020 Issue of “Townsend Letter” also explores gestational transmission of Lyme and alternative treatments.

Patient Matters

Disulfiram Shows Promise for People with Chronic Lyme Disease

Disulfiram Shows Promise for People with Chronic Lyme Disease

Patients recover health with old drug repurposed for Lyme after proving active against Bb in a test tube.

The Healing Power of Realistic, Practical Hope

The Healing Power of “Realistic, Practical Hope”

Meditation teacher shares how mindfulness helped him through chronic Lyme.

Advocacy

ILADS Guidelines Authors Defend Their Conclusion that Scientific Evidence from Lyme Clinical Trials is Weak

ILADS Guidelines Authors Defend Their Conclusion that Scientific Evidence from Lyme Clinical Trials is “Weak”

IDSA overstates the quality of the evidence it uses to deny care to chronically ill patients who fail standard treatment.

Sharing Alex’s Lyme Legacy with the Girl Scouts

Sharing Alex’s Lyme Legacy with the Girl Scouts

Project Tick aims to teach young girls about tick removal and Lyme disease prevention.

Stand with us. Be part of a community that cares.

Become a member and help us advocate for change, raise awareness and fund research that can improve patients’ lives.